Olga is an engagement manager in Deloitte’s Healthcare Strategy practice. Based in Boston, she has extensive experience in helping healthcare companies grow and transform to keep pace with the evolving healthcare landscape. Specifically, Olga focuses on innovation and growth for health plan, retail health, and life sciences clients.
Recent examples include behavioral health clinical product strategy at a national plan, growth strategy for a specialty pharmacy looking to diversify their assets and footprint, pharmacy consumer experience transformation planning, developing options to address the social determinants of health that impact members of a regional plan, and designing market-level provider engagement strategies for a new Medicare Advantage-focused regional plan.
In addition, Olga drives Deloitte’s global thinking on the ‘Future of Mental and Behavioral Health’ and the ‘Future of Pharmacy.’
Prior to joining Deloitte, Olga held various roles at IQVIA, helping life sciences clients bring new therapies to the US, EU, and Asian markets. Olga also has experience leading business operations for Edimer, a life sciences start-up focused on bringing a cure for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare disease, to market in the US and EU.